Leadership Team

James Green is Chairman, President and Chief Executive Officer of Harvard Bioscience. He was named President and Chief Executive Officer in July 2019 and Chairman of the Board of Directors in June 2017. Green has been a member of the Company’s Board of Directors since April 2015. Green served as President and Chief Executive Officer of Analogic Corporation (NASDAQ: ALOG) from 2007 to 2016. While leading the public company through the great recession, Analogic’s core revenues grew over 50%, and gross margins, operating margins and earnings per share dramatically improved. Immediately prior to becoming President and Chief Executive Officer of Harvard Bioscience, Green served as President of Spacelabs Healthcare, where he led a successful global restructuring, rationalizing the company’s cost structure and product portfolio and quickly stabilized revenues while significantly improving operating margins. Earlier in his career, Green was Regional Vice President of a division of Quest Diagnostics Corporation, Sr. VP & General Manager of Koninklijke Philips Electronics NV Global Computed Tomography Business and held various leadership positions at St. Jude Medical Inc., Beckman Instruments, McDonnell Douglas Corporation and Northrop Advanced Systems. Green earned a bachelor’s degree in electrical engineering from the University of Missouri at Columbia and a master’s degree in computer engineering from the University of Southern California and is a graduate of the Stanford University Executive Program.

David Balcom was named Senior Vice President, Operations at Harvard Bioscience in July, 2022. Prior to this role, Balcom worked with Cirtec Medical, a full-service contract design, development and manufacturing business supporting products across a broad spectrum of Medical Device sectors, where he also served as Senior Vice President of Operations.

Balcom’s career includes 15 years of broad operations work with Boston Scientific, St. Jude Medical and Abbott. Throughout his career, Balcom has spearheaded the successful development and execution of efficiency and growth strategies across an array of functional responsibilities including manufacturing, supply chain, quality, R&D, program management, facilities and freight and distribution.

Balcom transitioned to the Medical Device industry after serving for six years in the U.S. Army as an Infantry Officer Captain. He earned his B.S. in Electrical Engineering from the United States Military Academy at West Point, NY and later an M.B.A. in Finance from the University of Colorado.

Jennifer Cote was recently named Interim CFO and brings extensive experience in finance, strategy, and operations to the Harvard Bioscience team. Cote joined Harvard Bioscience in May 2022 as Vice President Global Finance and leads our Finance team with a focus on strong business partnership, controls, and fiscal management. She started her career as an auditor with Arthur Andersen and then spent over 22 years at the Bose Corporation in leadership roles in both finance and operations, including head of finance for Bose’s professional and headphones divisions, and a global process owner within the global business services team. Cote has led strategy development, lean and agile centers of excellence and digital portfolio management. She is a high impact operational leader who values driving results and accountability. Jennifer is a CPA and CGMA (Chartered Global Management Accountant) and holds a BS in Accounting from Villanova University School of Business.

With over 30 years of experience in the industries of life science, medical equipment and technologies, John Fry joined the Harvard Bioscience family in August 2022 as Chief Legal Counsel. John began his career as an electrical engineer and engineering manager, and has been named an inventor on ten U.S. patents. Prior to joining Harvard Bioscience, John worked both in private practice and in-house roles, serving the needs of multinational clients in the medical and technology industries.

John has both a bachelor’s and master’s degree in electrical engineering from Case Western Reserve University, as well as a law degree from Cleveland-Marshall College of Law.

As the former Senior Director of Applications and Business Intelligence for Haemonetics, Diane has extensive experience transforming sales analytics and fleet management, in addition to leading a number of projects that resulted in significant cost reductions. Before joining the Harvard Bioscience family, Diane held leadership roles in both private and public companies, including Kaz, Paychex, and Oracle, and is proud to have spent half her career as a consultant leading small teams through significant systems changes for a wide range of businesses.

When she’s not transforming IT systems, Diane enjoys football, flowers, and food – spending fall weekends with her husband, Jay, at their son’s football games. She also prides herself on spending her spare time in the spring and summer working on 15 gardens and a one-acre yard, leaving any leftover spare time to her love of cooking.

Diane holds a bachelor’s degree in finance from the University of San Francisco.

As the advocate of internal culture and people operations, Lori has dedicated the last two-plus decades to Harvard Bioscience, advocating for continual improvement in her broad responsibilities in human resources and administration. Before joining Harvard Bioscience, Lori was a proud entrepreneur and independent business owner for 15 years, with extensive medical device experience with GV Medical and St. Jude Medical. Outside of work, Lori continues to hone her skills as a member of Toastmasters International, as well as being an active officer at P.E.O., a philanthropic organization for women.

Lori holds a business degree from the University of Phoenix.

Nitya Shetty joined Harvard Bioscience in October 2021 as Vice President, Global Research and Development. Before joining Harvard Bioscience, Nitya worked at Spacelabs Healthcare for 15 years, specializing in Patient Monitoring and GE Consumer & Industrial for seven years.

Nitya has experience in developing innovative and high-performance R&D onshore/ offshoring centers across the span of multiple geographies that are constantly evolving and supporting revenue generation.  He played a key role in transforming medical devices to catch up with the latest consumer technologies for patient comfort and simple product lifecycle management.

Nitya has been successful in developing joint ventures, partners, and acquisitions to keep up with fast-changing technology, and in delivering products that exceed customer expectations. He is experienced in building and managing strong teams in advanced research and development, integration and systems, and operations management.

Ryan Wallace was named Senior Vice President Global Sales, Preclinical Systems in April 2020, where he leads our global direct sales concentrating on the leading Clinical Research Organizations (CROs), pharmaceutical companies and certain strategic accounts.  Wallace joined the company in January 2020, bringing extensive leadership and strategic selling experience and large account management of healthcare Integrated Delivery Networks, including over a decade of consecutive year-over-year double digit growth. Immediately prior to joining Harvard Bioscience, Wallace was a sales leader and top performer with Spacelabs Healthcare where he amassed a wealth of experience in healthcare capital equipment and service sales. Wallace has a BBA from Texas Lutheran University in Marketing and Management.